Eyenovia ' s Stock Is Soaring Today - Here ' s Why

William Blair initiated coverage on Eyenovia Inc EYEN, a biopharma company focused on developing therapies based on its Optejet device, which leverages a microdose array print (MAP) technology that allows consistent, reproducible dosing of ophthalmic drugs. Analysts Tim Lugo, Lachlan…#williamblair #eyenoviainceyen #optejet #map #timlugo #lachlanhanburybrown #johnboyle #npv #mydcombi #eyenovia
Source: Reuters: Health - Category: Consumer Health News Source Type: news
More News: Health | Opthalmology